Literature DB >> 2236453

Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression.

S R Dunlop1, B E Dornseif, J F Wernicke, J H Potvin.   

Abstract

In a multicentered study, 372 patients with mild major depressive disorder with a Hamilton Rating Scale for Depression (HAM-D) score of 15 to 19 were randomly assigned to 6 weeks of treatment with placebo or 20 mg, 40 mg, or 60 mg/day of fluoxetine. Patients were rated weekly for improvement and the appearance of side effects. Pattern analysis of treatment response showed more patients in the active drug treatment groups having a persistent or a delayed persistent response, the types of response specifically associated with active treatment. Analyses of mean changes in treatment measures showed little difference among treatment groups. This may be explained in part by different distributions in outcome, placebo patients having had a higher frequency of mild improvement with fewer negative and very positive outcomes. Response rate analyses favor the active treatments numerically, but only one of the comparisons is statistically significant. These findings suggest a specific role for fluoxetine treatment in mildly depressed patients who do not respond promptly or who respond inconsistently to nonspecific treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2236453

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  14 in total

Review 1.  Fortnightly review: drug treatment of depression.

Authors:  O Spigset; B Mårtensson
Journal:  BMJ       Date:  1999-05-01

Review 2.  Methodology of measuring the efficacy of antidepressants.

Authors:  F M Quitkin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Does study design influence outcome?. The effects of placebo control and treatment duration in antidepressant trials.

Authors:  Bret R Rutherford; Joel R Sneed; Steven P Roose
Journal:  Psychother Psychosom       Date:  2009-03-24       Impact factor: 17.659

4.  Medicine Cabinet: Drug treatment of depression.

Authors:  B Martensson; O Spigset
Journal:  West J Med       Date:  1999-08

Review 5.  Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis.

Authors:  Winfried Rief; Yvonne Nestoriuc; Anna von Lilienfeld-Toal; Imis Dogan; Franziska Schreiber; Stefan G Hofmann; Arthur J Barsky; Jerry Avorn
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

6.  Does differential drop-out explain the influence of study design on antidepressant response? A meta-analysis.

Authors:  Bret R Rutherford; Joel R Sneed; Steven P Roose
Journal:  J Affect Disord       Date:  2012-03-02       Impact factor: 4.839

7.  Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder.

Authors:  Per Bech; Daniel K Kajdasz; Vibeke Porsdal
Journal:  Psychopharmacology (Berl)       Date:  2006-09-08       Impact factor: 4.530

8.  Less is more in antidepressant clinical trials: a meta-analysis of the effect of visit frequency on treatment response and dropout.

Authors:  Bret R Rutherford; Timothy M Cooper; Amanda Persaud; Patrick J Brown; Joel R Sneed; Steven P Roose
Journal:  J Clin Psychiatry       Date:  2013-07       Impact factor: 4.384

9.  Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.

Authors:  C M Beasley; B E Dornseif; J C Bosomworth; M E Sayler; A H Rampey; J H Heiligenstein; V L Thompson; D J Murphy; D N Masica
Journal:  BMJ       Date:  1991-09-21

10.  Dose-response relationship of recent antidepressants in the short-term treatment of depression.

Authors:  Patricia Berney
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.